Market Place
Sourcing Support
Sanofi`s Cenrifki For Secondary Progressive Ms Recommended
24 Apr 2026 //
GLOBENEWSWIRE
Sanofi has `vigorous defense planned` for Dupixent patent cliff
24 Apr 2026 //
FIERCE PHARMA
Sanofi`s new COVID shot tops Moderna`s mNexspike in safety trial
20 Apr 2026 //
PRESS RELEASE
Sanofi, DKSH Partner to Boost Treatment Access in Malaysia
16 Apr 2026 //
PRESS RELEASE
Dupixent Receives EU Approval For Young Children With CSU
13 Apr 2026 //
PRESS RELEASE
Sanofi’s lunsekimig met primary and key secondary endpoints
07 Apr 2026 //
PRESS RELEASE
Sanofi, Incyte, Roivant, Alumis Advance In Skin Disease Research
31 Mar 2026 //
BIOSPACE
Sanofi Shares Phase 3 Amlitelimab Data for AD at AAD Meeting
28 Mar 2026 //
PRESS RELEASE
Dupixent Approved in Japan for Bullous Pemphigoid (BP)
24 Mar 2026 //
PRESS RELEASE
Kali signs deal with Sanofi to develop autoimmune Treatment
23 Mar 2026 //
REUTERS
Earendil Labs Secures $787M To Expand AI-Driven Biologics R&D
20 Mar 2026 //
PR NEWSWIRE
Sanofi launches innovation and operation centre in China
20 Mar 2026 //
REUTERS
Teva`s $400M Blackstone deal to fund Sanofi-partnered IBD drugTev
05 Mar 2026 //
GLOBENEWSWIRE
Sanofi inks $1.5B Deal For Sino Biopharm`s Novel Asset
05 Mar 2026 //
FIERCE PHARMA
Blueprint Reports 4-Year Data in Indolent Systemic Mastocytosis
28 Feb 2026 //
PR NEWSWIRE
EU CHMP Recommends Dupixent for Pediatric Chronic Urticaria
27 Feb 2026 //
PRESS RELEASE
Dupixent picks up 9th FDA approval
25 Feb 2026 //
PRESS RELEASE
Sanofi points to long-term efficacy of Teva-partnered IBD drug
17 Feb 2026 //
PRESS RELEASE
Beyfortus study published in The Lancet Infectious Diseases
16 Feb 2026 //
PRESS RELEASE
Sanofi completes the acquisition of Dynavax
10 Feb 2026 //
PRESS RELEASE
Roche Unveils Data Behind BTK Inhibitor`s Phase 3 MS Win
09 Feb 2026 //
FIERCE BIOTECH
Fierce Biotech Fundraising Tracker `26: Angitia & More
09 Feb 2026 //
FIERCE BIOTECH
NICE Recommends Dupilumab For Severe CRSwNP In England & Wales
06 Feb 2026 //
PHARMIWEB
Sanofi Shifts From mRNA Flu Vaccine As CEO Shows Confidence
30 Jan 2026 //
BIOSPACE
Sensorion Secures €60M Financing For Genetic Medicine Pipeline
28 Jan 2026 //
BUSINESSWIRE
Pfizer Retains Top Spot In Vaccine Rankings As Sanofi Slides
27 Jan 2026 //
FIERCE PHARMA
Sanofi`s Amlitelimab Confirms Its Potential in Atopic Dermatitis
27 Jan 2026 //
PRESS RELEASE
Recludix Doses First Subjects in Phase 1 STAT6 Inhibitor Study
12 Jan 2026 //
GLOBENEWSWIRE
Cytoreason Expands Sanofi Partnership For AI Drug Discovery
10 Jan 2026 //
PR NEWSWIRE
Diagonal Therapeutics Secures $125M Series B
08 Jan 2026 //
GLOBENEWSWIRE
Sanofi`s Tzield Under Priority Review For Children With Diabetes
05 Jan 2026 //
PRESS RELEASE
Tiziana Reports Annual Safety Data For Intranasal Foralumab
29 Dec 2025 //
GLOBENEWSWIRE
Sanofi to acquire Dynavax, Pushes Ahead on Adult Vaccines
27 Dec 2025 //
PRESS RELEASE
Dupixent Approved in Japan for Children Aged 6 to 11 Years
23 Dec 2025 //
GLOBENEWSWIRE
ADEL Secures $1.04B Sanofi Deal for ADEL-Y01
15 Dec 2025 //
PR NEWSWIRE
Sanofi Updates Tolebrutinib for Primary Progressive MS
15 Dec 2025 //
GLOBENEWSWIRE
Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership
15 Dec 2025 //
BUSINESSWIRE
FDA Launches Probe Into Safety Of Approved Anti-RSV Antibodies
10 Dec 2025 //
BIOSPACE
Sanofi Invests In Indupro Therapeutics For Autoimmune Bispecific
10 Dec 2025 //
BUSINESSWIRE
Sanofi`s Blueprint Medicines Showcases Ayvakit Benefits At ASH
05 Dec 2025 //
PR NEWSWIRE
Sanofi completes acquisition of Vicebio
05 Dec 2025 //
PRESS RELEASE
Labgenius Pharma Collaborates With Sanofi On AI Antibody Program
04 Dec 2025 //
PRESS RELEASE
EU Approves Dupixent As First Targeted Drug For Chronic Urticaria
26 Nov 2025 //
PRESS RELEASE
Lifordi Immunotherapeutics Secures Sanofi Backing
18 Nov 2025 //
BUSINESSWIRE
Sanofi`s Teizeild Recommended For EU Approval For Stage 2 T1D
15 Nov 2025 //
PRESS RELEASE
Dupixent Study Meets Endpoints; sBLA Under FDA Priority Review
07 Nov 2025 //
PRESS RELEASE
Zag Bio Emerges With $80M Funding For Tregs Diabetes Candidate
28 Oct 2025 //
FIERCE BIOTECH
Sanofi Drops Toddler RSV Vaccine After Ph. 3 Heads For Failure
24 Oct 2025 //
FIERCE BIOTECH
Sanofi, Medidata Partner to Accelerate Therapy Development
24 Oct 2025 //
PHARMIWEB
Sanofi’s Efdoralprin Alfa Meets Ph2 Endpoints in AATD Emphysema
22 Oct 2025 //
PRESS RELEASE
Alphamedixtm Phase 2 Data Back New Targeted Alpha Therapy
20 Oct 2025 //
PRESS RELEASE
Sanofi`s Tzield Fast-Tracked For Stage 3 Type 1 Diabetes Review
20 Oct 2025 //
PRESS RELEASE
Evoq Therapeutics Signs On With Sanofi In $500M Partnership
17 Oct 2025 //
FIERCE BIOTECH
Expedition Therapeutics Secures $165M In Series A Funding
09 Oct 2025 //
PHARMIWEB
Sanofi Inks Pact with Canadian Tech Company to Bring AI to R&D
09 Oct 2025 //
FIERCE BIOTECH
AlphaMedix (212Pb-DOTAMTATE) Meets Ph2 Endpoints In GEP-NET Study
08 Oct 2025 //
PRESS RELEASE
Biovaxys Appoints Former Sanofi Vaccines Executive to Board
08 Oct 2025 //
PR NEWSWIRE
Novavax Advances Sanofi Partnership With Nuvaxovid EU Marketing
07 Oct 2025 //
PR NEWSWIRE
Sanofi Ventures Invests In Quanthealth To Boost AI-Driven Trial
01 Oct 2025 //
BUSINESSWIRE
Star Therapeutics Secures $125m In Series D Funding
30 Sep 2025 //
BUSINESSWIRE
